PharmaVoice

MAY 23, 2024

Promises made by pharma and biotech companies show confidence in the future of their business and dedication to financial success, R&D and environmental protection.

Sales goal 130

Sales goal Sales Pharma 130

Sales Talent

JANUARY 20, 2022

At the beginning of each year, we compile our sales hiring forecast by looking at the overall hiring forecasts for the year made by Manpower, Glassdoor, Indeed, Monster, and the Bureau of Labor & Statistics (BLS). 2021 Sales Hiring in Review. 2021 Sales Hiring in Review. 2022 Sales Forecast for Hiring.

Sales 130

Sales B2B Sales Competition Insurance 130

pharmaphorum

DECEMBER 7, 2023

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of the decade, a sharp increase on earlier predictions.

Sales 103

Sales 103

Pharmaceutical Technology

SEPTEMBER 18, 2024

Kisqali generated $2bn in sales last year, with broader approvals forecasting sales of over $8bn by 2030, per GlobalData analysis.

Sales 98

Sales Patients FDA 98

Pharmaceutical Technology

DECEMBER 16, 2022

The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% The figure below summarises the endometriosis market growth across the 7MM from 2020 to 2030. At the end of 2030, the US will contribute approximately 81.3% of 7MM sales.

Marketing 59

Marketing Side effects Sales Safety 59

World of DTC Marketing

MAY 16, 2022

Sales of Mounjaro could approach $14 billion annually by 2030. This is going to be a major change in public health.” That is a clear indication that Lilly sees huge dollar signs with this drug, and damn the side effects. A matter of trust?

Food and Drug Administration 218

Food and Drug Administration Side effects Pharma Patients 218

World of DTC Marketing

JULY 17, 2022

A Harvard study found that almost half of Americans are expected to be obese by 2030, accounting for up to 18 percent of healthcare spending on related conditions, ranging from heart disease and stroke to osteoarthritis. . Novo Nordisk more than doubled its sales targets for obesity drugs to $3.7bn by 2025.

Side effects 209

Side effects Doctors Insurance Prescription 209

Scott Burrows

APRIL 17, 2023

oral care market is around $34 billion with a projected valuation of somewhat over $51 billion by 2030. As a motivational dental sales keynote speaker, I know most observers might say, “A growth rate of nearly 5.5% According to the latest market research data, the current valuation of the U.S. is pretty darn good.”…

Sales 52

Sales Marketing Medical sales Medical 52

Pharmaceutical Technology

JANUARY 29, 2025

Enhertu is projected to reach $13.9bn in sales by 2030, according to GlobalDatas Pharma Intelligence Center.

Patients 59

Patients Sales FDA Pharma 59

PharmExec

JUNE 1, 2023

Bloomberg Intelligence survey credits increased medication access for potential spike.

Sales 52

Sales Medical 52

Pharmaceutical Technology

JANUARY 22, 2025

Tagrisso and Imfinzi are projected to generate global sales of $8bn and $7bn, respectively, by 2030, according to GlobalData.

Sales 59

Sales 59

Pharmaceutical Technology

AUGUST 20, 2024

As obesity rates rise and trust in GLP-1R products grows, sales are forecast to increase four-fold from 2023 to 2030.

Marketing 59

Marketing Sales 59

Contrarian Sales Techniques

JANUARY 30, 2023

Medical sales can be a lucrative job , but it depends on a number of factors , including the specific products or services being sold, the company or industry sector, and the individual's sales performance. Additionally, the medical sales industry is expected to grow in the coming years.

Medical sales 52

Medical sales Sales Medical Healthcare Provider 52

pharmaphorum

JULY 14, 2022

Grünenthal is paying up to €500 million ($501 million) for rights to Nebido (testosterone undecanoate), which is sold in around 80 countries worldwide for testosterone deficiency and made sales of €117 million last year.

Competition 97

Competition Pharma Sales Medicine 97

European Pharmaceutical Review

FEBRUARY 8, 2023

GlobalData predicts Bristol-Myers Squibb’s Breyanzi and Gilead’s Yescarta are set to have high annual sales in the forecast period. Yescarta for blood cancer Yescarta is targeting expansions into the first line for diffuse large B-cell lymphoma (DLBCL) and second line for follicular lymphoma in 2030. billion in 2031.

Marketing 98

Marketing Sales Physicians Patients 98

Pharmaceutical Technology

NOVEMBER 27, 2024

With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative market.

Sales 52

Sales Marketing 52

Quantified

AUGUST 30, 2022

Without a successful sales team , an organization can’t thrive. The sales team turns leads into customers, guiding prospects through their concerns until they arrive at the sale. That leads to another question: how do you identify and hire the best sales manager for your organization?

Sales Management 52

Sales Management Management Sales Leads 52

European Pharmaceutical Review

FEBRUARY 3, 2023

billion by 2030 The post France gets new sterile liquid drug manufacturing facility appeared first on European Pharmaceutical Review. HPAPI contract manufacturing to value $14.6

Manufacturing 98

Manufacturing Pharmaceutical Marketing Sales 98

Every Ancillary

MAY 14, 2021

Most seasoned medical sales representatives have carried several different products or services over their careers. Between emerging technologies, expiring patents, and ever-changing insurance coverage, the role of a medical sales professional is to constantly adapt and learn new things. Gives you an area of expertise.

Medical sales 52

Medical sales Medical Sales Insurance 52

Spotio

FEBRUARY 9, 2023

Furthermore, the organization predicts it will outpace the GDP by 2030. This is great news for those in medtech sales! And your reps need to adopt an omnichannel process that uses all of the medical device sales channels at their disposal. Each threatens to derail your medical device sales process in some way.

Sales 52

Sales Medical Doctors Sales process 52

Spotio

MARCH 25, 2024

You need to optimize your company’s solar sales funnel. Of course, wanting to improve your solar sales process and actually doing it are different things. Understanding Solar Sales Before we discuss the various stages of the solar sales funnel, let’s zoom out and analyze the industry as a whole.

Sales 52

Sales Prospecting Sales process Sales pitches 52

Pharmaceutical Technology

JUNE 7, 2023

In addition, Mounjaro is estimated to gain sales of around $20bn by 2030 and become the leading GLP-1 in the obesity market, as well as in T2D. In 2022, Lilly reported sales for Mounjaro were approximately $500m, but this is expected to increase significantly in 2023 due to strong demand for the T2D drug.

Leads 98

Leads Marketing Sales FDA 98

European Pharmaceutical Review

OCTOBER 12, 2022

If the drug is approved, GlobalData estimates that global sales for HMTM will reach $127 million by 2030. TauRx intends to submit its anti-tau therapy for regulatory approval in the US and Canada in 2023. appeared first on European Pharmaceutical Review.

Side effects 98

Side effects Safety Patients Sales 98

pharmaphorum

JANUARY 19, 2023

per share deal includes $8 per share upfront, worth around $576 million, with the remainder in the form of a contingent value right (CVR) that will be paid to Concert shareholders if deuroxilitinib meets certain sales targets within a set time limit. The $11.50 The report predicts that the alopecia areata market will grow to as much as $2.5

Pharma 98

Pharma Marketing FDA Leads 98

European Pharmaceutical Review

JULY 31, 2024

Global sales of $13.9 Mounjaro, Zepbound, and Ozempic are expected to surpass Merck & Co’s Keytruda in global analyst consensus sales by 2030″ This is despite an “overall 1.6 billion, with combined global sales of $5.3 Projected sales for Mounjaro, Zepbound, and Ozempic are $27.4 percent to $33.7

Biopharma 52

Biopharma Sales Manufacturing Pharmaceutical 52

Pharmaceutical Technology

JUNE 21, 2023

UniQure announced that it had received $100m from this first commercial sale milestone, on top of a $450m upfront payment. It is eligible for up to $1.6bn based on future milestones, as well as royalties amounting to more than 20% of net product sales. Haemophilia B is a rare condition.

Patients 98

Patients Food and Drug Administration Sales Marketing 98

European Pharmaceutical Review

AUGUST 22, 2024

Based on their rising popularity to treat type 2 diabetes and obesity, GlobalData has predicted that sales of glucagon-like peptide-1 receptor (GLP-1R) drugs will increase fourfold to an estimated $142 billion by 2030. 1 Considering the 11 approved GLP-1R drugs “generated $37.2 1 Considering the 11 approved GLP-1R drugs “generated $37.2

Medicine 59

Medicine Marketing Manufacturing Sales 59

pharmaphorum

JULY 18, 2022

The market research group recently predicted Vydura and atogepant will achieve sales of $35 million and $57 million, respectively, by 2030 in the five major European markets of France, Germany, Italy, Spain, and the UK.

Sales 52

Sales Marketing Patients FDA 52

Infuse Medical

DECEMBER 17, 2024

Medical video creation can increase sales, improve brand awareness, and draw possible patients. billion by 2030, at a CAGR of 33.5% from 2023 to 2030. Our area of expertise at Infuse Med is creating medical marketing videos stressing the specific selling features of medical equipment, treatments, and services.

Training 130

Training Medical Healthcare Healthcare 130

Pharmaceutical Technology

MAY 9, 2023

in sales milestones. It is calculated that China will have around five million people with Parkinson’s disease by 2030, because of its ageing population. Acorda will receive $2.5m in an up-front payment, up to $6m in a near-term milestone payment and $3m following regulatory approval, along with $132.5m

Distribution 52

Distribution Medical Pharmaceutical Sales 52

pharmaphorum

AUGUST 2, 2022

Merck would not be the first company to do so, Gilead was prepared to pay $21 billion for Immunomedics and thereby add Trodelvy (sacituzumab govitecan) to its portfolio, as part of the company’s plans to generate one-third of its revenues from cancer drugs in 2030. Looking to the future. billion in revenue last year.

Marketing 98

Marketing Prospecting Sales Pharma 98

Contrarian Sales Techniques

NOVEMBER 19, 2024

For pharma sales reps, this shift changes the conversation. As someone in pharma sales, I see the impact this has on our market. million by 2030, exhibiting a compound annual growth rate (CAGR) of 4.08% during the forecast period from 2023 to 2030 [ source ]. In 2022, it was valued at approximately $898.7

Medicine 40

Medicine Pharma sales reps Healthcare Provider Healthcare 40

Pharmaceutical Technology

MARCH 29, 2023

This next extension beyond 2030 is a testament to the success and trust of the partnership, as well as to the high degree of confidence placed in our platforms and the complementary approach to generating a leading pipeline of highly innovative drug candidates.

Food and Drug Administration 52

Food and Drug Administration Medicine Food Sales 52

pharmaphorum

OCTOBER 18, 2022

billion on offer if MGD024 makes it through to market in multiple indications, as well as tiered royalties on sales. million in sales in the second quarter of this year, when MacroGenics posted a net loss of around $41 million and closed out the quarter with $138 million in cash reserves. It brought in $4.7

Sales 52

Sales Marketing Patients 52

pharmaphorum

DECEMBER 13, 2022

GSK has selected a site currently being constructed on the corner of New Oxford Street and Earnshaw Street – known as the Earnshaw building – for its new HQ, which is currently located to the west of the capital in Brentford and put up for sale last year.

Transportation 59

Transportation Biopharma Healthcare Healthcare 59

pharmaphorum

JANUARY 16, 2023

Analysts at GlobalData said last year that they expect LY03010 to launch in 2024 and bring in sales of around $64 million in 2030. It will have a mountain to climb to catch up with the $1 billion in quarterly currently being recoded with J&J’s Invega franchise, however.

FDA 52

FDA Marketing Pharma Competition 52

Contrarian Sales Techniques

FEBRUARY 24, 2023

Social programs and initiatives: The government will establish a National Land Committee Waqf to contribute to the expansion of the Islamic social finance sector by 2030. RM100 million allocated for Jualan Rahmah sales in all Parliamentary constituencies. Healthcare and Education: RM36.3 million people.

Government 52

Government Education Medical sales reps Food 52